Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BONiFIN: Ibandronate loading dose for pain in breast cancer bone metastases
2006-000697-74Phase 2Terminated
- Sponsor
- BONiFIN
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ibandronic acid in breast cancer and bone metastases, sponsored by BONiFIN. Primary endpoint: Pain response at day 7. Started Apr 2006; status: terminated.
02
Drugs
ibandronic acid
03
Conditions
breast cancerbone metastases
Beyond the preview
Go deeper on 2006-000697-74.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000697-74.